Liquidia Technologies (LQDA) Competitors $22.45 +0.00 (+0.02%) As of 10:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. STVN, IRTC, BLCO, GKOS, TMDX, NVST, LIVN, SLNO, WRBY, and INSPShould you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Soleno Therapeutics (SLNO), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry. Liquidia Technologies vs. Its Competitors Stevanato Group iRhythm Technologies Bausch + Lomb Glaukos TransMedics Group Envista LivaNova Soleno Therapeutics Warby Parker Inspire Medical Systems Stevanato Group (NYSE:STVN) and Liquidia Technologies (NASDAQ:LQDA) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings. Which has more risk & volatility, STVN or LQDA? Stevanato Group has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500. Do analysts prefer STVN or LQDA? Liquidia Technologies has a consensus price target of $32.11, suggesting a potential upside of 43.01%. Given Liquidia Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Liquidia Technologies is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.00 Does the media refer more to STVN or LQDA? In the previous week, Liquidia Technologies had 3 more articles in the media than Stevanato Group. MarketBeat recorded 7 mentions for Liquidia Technologies and 4 mentions for Stevanato Group. Liquidia Technologies' average media sentiment score of 0.90 beat Stevanato Group's score of 0.59 indicating that Liquidia Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Liquidia Technologies 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, STVN or LQDA? Stevanato Group has higher revenue and earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group€1.15B7.14€127.45M€0.5450.00Liquidia Technologies$14M138.08-$130.39M-$1.70-13.21 Do insiders and institutionals have more ownership in STVN or LQDA? 64.5% of Liquidia Technologies shares are held by institutional investors. 30.1% of Liquidia Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is STVN or LQDA more profitable? Stevanato Group has a net margin of 11.73% compared to Liquidia Technologies' net margin of -732.17%. Stevanato Group's return on equity of 10.34% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group11.73% 10.34% 6.21% Liquidia Technologies -732.17%-232.96%-60.81% SummaryLiquidia Technologies beats Stevanato Group on 9 of the 17 factors compared between the two stocks. Get Liquidia Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.92B$3.13B$5.72B$10.39BDividend YieldN/A2.36%5.53%4.58%P/E Ratio-13.1020.9776.1626.62Price / Sales138.08254.61471.8492.08Price / CashN/A46.3537.4661.85Price / Book24.679.8313.336.46Net Income-$130.39M-$52.73M$3.29B$271.49M7 Day Performance-10.18%4.18%2.29%2.97%1 Month Performance-16.34%5.73%4.44%7.56%1 Year Performance121.88%18.32%75.18%30.09% Liquidia Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia Technologies3.9348 of 5 stars$22.45+0.0%$32.11+43.0%+126.1%$1.92B$14M-13.1050STVNStevanato GroupN/A€26.21-0.8%N/A+37.5%€7.94B€1.19B48.545,521IRTCiRhythm Technologies1.1094 of 5 stars$176.16-2.0%$163.82-7.0%+150.5%$5.78B$657.23M-60.122,000Positive NewsAnalyst ForecastBLCOBausch + Lomb1.9382 of 5 stars$15.23+0.2%$15.56+2.2%-22.4%$5.38B$4.79B-19.5213,500GKOSGlaukos4.5598 of 5 stars$80.72-2.5%$124.83+54.6%-33.9%$4.75B$383.48M-48.92780Analyst ForecastTMDXTransMedics Group2.2994 of 5 stars$114.29-0.2%$122.11+6.8%-24.4%$3.91B$441.54M59.22210NVSTEnvista3.7752 of 5 stars$21.12+0.5%$20.92-0.9%+9.5%$3.49B$2.51B65.9912,300Positive NewsLIVNLivaNova2.9111 of 5 stars$55.43-1.4%$59.71+7.7%+5.2%$3.07B$1.25B-14.252,900Positive NewsSLNOSoleno Therapeutics4.4441 of 5 stars$51.17-4.6%$115.09+124.9%+18.1%$2.85BN/A-12.3630Gap UpWRBYWarby Parker1.5988 of 5 stars$26.37-1.4%$24.06-8.8%+95.6%$2.81B$771.32M-376.723,780INSPInspire Medical Systems4.8394 of 5 stars$80.90+1.1%$164.50+103.3%-64.5%$2.37B$802.80M46.761,246Analyst Downgrade Related Companies and Tools Related Companies Stevanato Group Competitors iRhythm Technologies Competitors Bausch + Lomb Competitors Glaukos Competitors TransMedics Group Competitors Envista Competitors LivaNova Competitors Soleno Therapeutics Competitors Warby Parker Competitors Inspire Medical Systems Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LQDA Stock Alerts